Position in INCY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$201,872,999
-$24,199,085 QoQ
Shares Held
2,144,847
-6.3% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.82%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 64.50226985887572.ToString("F0")%
Shared 0.ToString("F0")%
None 35.497730141124286.ToString("F0")%
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026LOS ANGELES CAPITAL MANAGEMENT LLC holds $690,323,052 across 153 Biotechnology names. INCY ranks #1 (29.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
This page
|
2,144,847 | $201,872,999 | |
| 2 | EXEL |
Exelixis, Inc.
|
3,102,634 | $133,071,972 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
78,880 | $60,945,843 | |
| 4 | RPRX |
Royalty Pharma plc
|
971,927 | $46,623,338 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
689,915 | $44,589,206 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
2,289,602 | $40,938,083 | |
| 7 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
88,278 | $29,208,541 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
64,937 | $28,996,967 |
All Filings in INCY
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $201,872,999 | 2,144,847 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $226,072,084 | 2,288,874 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $149,364,912 | 1,761,171 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $21,345,468 | 313,443 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $19,787,376 | 326,794 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $28,125,373 | 407,201 | Shares | Sole | 2025-02-04 | |
| 2024-09-30 | $13,867,449 | 209,795 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $22,454,314 | 370,411 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $87,759,778 | 1,540,456 | Shares | Sole | 2024-04-05 | |
| 2023-12-31 | $98,598,885 | 1,570,296 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $66,167,562 | 1,145,362 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $10,396,995 | 167,020 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $46,789,187 | 647,422 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $50,777,661 | 632,192 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $33,865,581 | 508,187 | Shares | Sole | 2022-11-02 | |
| 2022-06-30 | $21,778,167 | 286,668 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $31,402,032 | 395,392 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $58,419,940 | 795,912 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,731,605 | 25,176 | Shares | Sole | 2021-11-08 | |
| 2021-03-31 | $1,375,332 | 16,923 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $1,743,601 | 20,046 | Shares | Sole | 2021-03-10 | |
| 2020-09-30 | $2,900,307 | 32,319 | Shares | Sole | 2020-11-02 | |
| 2020-06-30 | $18,941,566 | 182,183 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $77,982,993 | 1,064,905 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||